Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta

In summary, resveratrol can inhibit sFlt-1 release and up-regulate heme oxygenase-1; thus, may offer therapeutic potential in preeclampsia.